Travere Therapeutics (TVTX) Asset Utilization Ratio (2014 - 2026)

Travere Therapeutics' Asset Utilization Ratio history runs 13 years deep, the most recent figure standing at 0.12 for Q1 2026.

• Quarterly Asset Utilization Ratio fell 125.24% year-over-year to 0.12 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.12 (down 125.24% YoY) and the FY2025 annual result came in at 0.02, down 95.4% from the prior year.
• Asset Utilization Ratio was 0.12 for Q1 2026 at Travere Therapeutics, up from 0.2 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 0.6 in Q2 2025 and bottomed at 0.2 in Q4 2025.
• A 5-year average of 0.19 and a median of 0.17 in 2023 frame the typical range for Asset Utilization Ratio.
• Annual changes were most pronounced in 2023 — Asset Utilization Ratio soared 1156.65% — and 2025, when it tumbled 147.6%.
• Travere Therapeutics' Asset Utilization Ratio stood at 0.16 in 2022, then grew by 14.44% to 0.18 in 2023, then soared by 137.01% to 0.42 in 2024, then tumbled by 147.6% to 0.2 in 2025, then surged by 40.21% to 0.12 in 2026.
• Business Quant data shows TVTX's Asset Utilization Ratio at 0.12 in Q1 2026, 0.2 in Q4 2025, and 0.57 in Q3 2025.